Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP1 | Q9NZ08 | 4/20 | 0.46 |
| ▸ | ANPEP | P15144 | 3/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | IL1RN | P18510 | 2/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23542541 | 0.74 | NPC1 (0.53) | TSHRALDH1A1 | |
| SCHEMBL8459566 | 0.74 | ALDH1A1 (0.38) | ERAP1ANPEPTSHRLAP3ALDH1A1 | |
| SCHEMBL28153833 | 0.74 | TSHR (0.56) | ERAP1ANPEPERAP2TSHRCYP2D6 | |
| SCHEMBL28294078 | 0.73 | TSHR (0.47) | TSHRCYP2D6LAP3ALDH1A1CETP | |
| Hydrochloric Acid SCHEMBL18954361 | 0.73 | NPC1 (0.51) | TSHRALDH1A1 | |
| SCHEMBL28111320 | 0.73 | POLB (0.42) | ERAP1ANPEPERAP2TSHRLAP3 | |
| SCHEMBL3380549 | 0.73 | S1PR2 (0.46) | ERAP1ANPEPERAP2TSHRS1PR2 | |
| SCHEMBL7627056 | 0.72 | ALPI (0.50) | ANPEPERAP2LAP3 | |
| SCHEMBL28464109 | 0.72 | LMNA (0.65) | CYP2D6ALDH1A1 | |
| SCHEMBL5934300 | 0.71 | ALDH1A1 (0.41) | TSHRCYP2D6LAP3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413762-B1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN INT INC (US) | 2000-07-12 | — | — | EP | disclosed |
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | disclosed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |